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Two common nematodes that affect young horses are cyathostomes (small 
strongyles) and Parascaris equorum (ascarids).  It has been recently found that 
populations of these nematodes are resistant to common anthelmintics used to control 
them.  Small strongyles have been found to be resistant to pyrantel and fenbendazole, 
while ascarids have been found to be resistant to ivermectin.  This represents a unique 
dilemma in controlling the gastrointestinal nematode population in the foal.  It has been 
shown in other host species that combination anthelmintics can be used to successfully 
treat resistant nematodes.  The current study utilized 28 foals and was conducted from 
April to November 2007.  The foals were allocated into age cohorts and randomly 
assigned a treatment regimen.  Group I was administered ivermectin at 0.2 mg/kg BW.  
Group II was administered ivermectin at 0.2-mg/kg BW and pyrantel pamoate at 6.6 
mg/kg BW.  Group III was administered ivermectin at 0.2-mg/kg BW and fenbendazole 
at 10 mg/kg BW.  Group IV was administered pyrantel pamoate at 6.6 mg/kg BW and 
fenbendazole at 10 mg/kg BW.  Fecal samples were collected at time of treatment and 
two wk post treatment to determine effectiveness in removing egg producing adult 
 iv 
nematodes.  Each age cohort was then treated 30 d later with a different anthelmintic or 
combination.  That is, foals in group I were treated as those in group II, group II to 
treatment III, group III to treatment IV, and group IV to treatment I.  Over a period of 4 
mo, each foal received at least one treatment in consecutive order. 
The difference of egg counts (pre-treatment minus post-treatment) for small 
strongyles treated with ivermectin (IVM) was 29.39 eggs per g (EPG), 5.44 EPG for 
ivermectin with pyrantel (PRT), 3.85 EPG for ivermectin with fenbendazole (FBZ), and 
-8.32 EPG for pyrantel with fenbendazole.  There was a significant difference when 
comparing IVM to IVM+PRT (P = 0.0018), IVM vs. IVM+FBZ (P = 0.0010), and IVM 
vs. PRT+FBZ (P < 0.0001).  IVM was more effective than each of the other treatments.  
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 Two gastrointestinal nematodes are of particular importance in foal health.  
Normally only foals are infected with Parascaris equorum (ascarid), and as the young 
horse is exposed to ascarids, they usually acquire immunity.  Thus, the parasite is not 
typically found in adult horses.  Strongyle type worms (40 species in North America) 
infect all ages of horses, but the unique combination of cyathostomes (small strongyles) 
and ascarids is only found in foals.  Foals do not exhibit patent infections of either 
parasite until they are approximately 2 mo of age, due to the long prepatent period, the 
time from infection until mature, egg-laying adults develop.   
 Historically anthelmintics, particularly ivermectin, have been used to control 
these nematodes in foals.  Ivermectin continues to be extremely effective against 
cyathostomes, but may not be as effective against ascarids (Boersema et al., 2002; Hearn 
and Peregrine, 2003; Lyons et al., 2006; Slocombe et al., 2007; Craig et al., 2007; 
Lindren et al., 2008).  Other anthelmintics, pyrantel and fenbendazole, are effective 
against ascarids but have a diminishing effect on the small strongyles (Lyons et al., 
1996; Lyons et al., 1999; Tarigo-Martinie et al., 2001; Kaplan, 2002; Kaplan et al., 
2004).  This represents a unique problem, one parasite is resistant to one class of 
anthelmintic and another parasite is resistant to another class, all while being in the  
____________ 
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same host.  In other host species, such as sheep and goats, the use of anthelmintic 
combinations has been tested with positive results against nematodes resistant to 
multiple classes of anthelmintics (Miller and Craig, 1996).  The objective of this study 
was to determine whether combinations of anthelmintics can be utilized to effectively 




REVIEW OF LITERATURE 
 
Parascaris equorum 
 The first, Parascaris equorum (ascarids) may cause coughing and nasal 
discharge, due to larval migration from the intestines through the lungs, reduced weight 
gain, lack of condition, lethargy, depression, and even death from intestinal obstruction 
of mature ascarids (Clayton and Duncan, 1978; Clayton, 1986).  Infections of ascarids 
are acquired naturally, soon after birth by ingestion of infective eggs during grazing, or 
investigation of their surroundings if housed indoors.  Ascarid eggs are passed in feces 
and may become infective within 10 d under suitable environmental conditions.  If 
conditions are favorable, eggs can remain viable for years due to the thick, three-layered 
protective shell, which provides environmental resistance.  The mature larvated egg 
hatches in the intestinal tract after ingestion by a foal.  Within 24 h, larvae penetrate the 
liver and spend 1 wk traveling through the hepatic parenchyma before moving on to the 
lungs.  Larvae are present in the pulmonary parenchyma and airways for an additional 
week.  Larvae return to mature in the small intestine via the tracheoesophageal junction 
and can be found in the duodenum as early as 2 wk after infection.  The prepatent period, 
time from infection to beginning of egg production by female adults, is variable, with a 
range of 72 to 110 d.  Adult ascarids are extremely fecund, with an approximate output 
of greater than 50 million eggs shed from a foal per day (Clayton, 1986).   
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 Parascaris is a highly antigenic and immunogenic parasite of foals.  Foals 
develop acquired immunity to the worm by the time they are one year of age.  Bello et 
al. (1974) found that as precipitin titers to whole-worm Parascaris antigen increased, the 
number of eggs per gram in fecal material decreased.  Titers increased gradually from a 
nonspecific reaction at birth to a titer of 24 by 5 to 8 wk, maintained these levels until 
wk 20, and then rose sharply to wk 28.  The titers continued to increase as yearlings 
developed an active protective immunity (Bello et al., 1974 and Bello, 1985). 
Small strongyles 
 The second group of gastrointestinal nematodes important to foal health are small 
strongyles (cyathostomes).  There are over 40 species in North America belonging to the 
nematode subfamily (Cyanthostominae).  The eggs produced are similar to those of large 
strongyles (Strongylus vulgaris) but cyathostomes usually comprise over 95% of the 
strongylid eggs in a fecal sample.  Small strongyles infect all ages of horses, but the 
unique combination with ascarids is only found in young horses (Reinemeyer, 1986). 
 Clinical signs of naturally acquired cyanthostome infections include loss of 
weight and decreased rate of gain, emaciation, general debility, and possible progression 
to mortality.  Experimental infections have resulted in pyrexia, tachycardia, anorexia, 
diarrheic stools, listlessness, and failure to shed winter hair coat.  Experimental 
infections have also resulted in decreased or changes in enterocolic motility, which is of 
great importance, since changes in motility are commonly associated with colic in horses 
(Reinemeyer, 1986).  Larval cyanthostomiasis is common in young horses (1 to 3 years 
of age), and is related to the emergence of excysted larvae from the walls of the large 
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intestine or penetration of the mucosa by infective 3rd stage larvae (L3) strongyles.  
Clinical signs include weight loss, diarrhea, pyrexia, and subcutaneous (especially 
ventral) edema (Lyons et al., 2000). 
 Horses become infected with cyathostomes by ingestion of the L3 larva during 
grazing.  They have a five-stage direct life cycle with adult females living in the cecum 
and large intestine of the horse and producing eggs that are passed in the feces.  Under 
favorable environmental conditions (temperature and moisture being the most crucial), 
an embryo develops within the egg and the first stage larva hatches.  Further 
development occurs to the second and third stage larvae.  The infective L3, encased in a 
sheath, resides on vegetation where it is then ingested by the grazing horse.  Infective L3 
larvae are exsheathed in the small intestine and penetrate the mucosa in the cecum and 
large intestine.  They molt to fourth stage larvae (L4) within a tissue cyst of host origin 
within 6 to 12 d.  They arrest within the cysts for 1 to 2 mo before emergence and 
entrance into the lumen of the large bowel and develop into adults.  Emergence is often 
seasonal, occurring in the first month of the yr in a northern temperate climate.  The 
prepatent period varies among species of parasite and age of host, usually between 5.5 to 
14 wks.  Adult cyathostomes are plug feeders, removing small bits of large intestinal 
mucosa as they feed, resulting in mucosal ulceration (Reinemeyer, 1986 and Lyons et 
al., 2000). 
Anthelmintics   
 In order to control the nematodes within the young horse, anthelmintics 
(antiparasitic drugs) are administered along with management practices to control 
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exposure.  When using anthelmintics, the intention is to remove the adult egg-laying 
stages from the gastrointestinal tract of the animal, and therefore lessen the effects on the 
animal and environmental contamination (Drudge and Lyons, 1966).  There are three 
major classes of anthelmintics currently used to control gastrointestinal nematodes in 
horses: benzimidazoles (fenbendazole, oxfendazole, oxibendazole, others), 
tetrahydropyrimidines (pyrantel salts), and avermectin/milbemycins (macrocylic 
lactones; ivermectin and moxidectin).  Piperazine and phenothiazine have been used in 
the past, but are presently infrequently used.  When first introduced, all of these drugs 
had good to excellent efficacy against cyathostomes and ascarids.  However, it is an 
increasing concern that both nematodes are developing resistances to one or more of 
these drugs (Kaplan, 2002). 
 When first introduced in the 1980’s, ivermectin (22,23-Dihydroavermectin B1) 
was extremely effective against small strongyles and ascarids in young and mature 
horses.  In early studies, there was a >99% reduction in the number of small strongyles 
when ivermectin was administered via injection or oral paste at a rate of 0.2 mg 
ivermectin/kg BW (Klei and Torbert, 1980; Craig and Kunde, 1981; Yazwinski et al., 
1982a).  Similarly, there was a 96 to 100% reduction in adult Parascaris (Egerton et al., 
1981; Yazwinski et al., 1982b) and a 98.5% reduction in immature ascarids when 
administered IM at 0.2-0.3 mg/kg BW (Yazwinski et al., 1982b).  Ivermectin acts on the 
nematode by enhancing the effect of the neurotransmitter -aminobutyric acid on the 
nervous system, causing irreversible, flaccid paralysis.  The nematode can then no longer 
maintain its position in the digestive tract and is eliminated (Austin et al., 1991). 
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 The second class of anthelmintics, benzimidazoles, exerts antiparasitic activity 
by inhibiting nematode energy metabolism.  Starvation of the worm results from 
inhibition of microtubular polymerization, decreasing nutrient absorption by the 
tegmental and intestinal cells (Austin et al., 1991).  DiPietro et al. (1984) found that 10 
mg/kg BW of fenbendazole (a benzimidazole) was highly effective against both 
immature and mature Parascaris when experimentally infected.  Similarly, it was found 
that fenbendazole given for 5 d at a rate of 10 mg/kg BW killed the migrating larvae 
(DiPietro, 1984).  When given at a rate of 7.5 mg/kg BW for 5 d consecutively, 
fenbendazole resulted in a 90% reduction in adult cyathostomes and an approximately 
95% reduction in the larval stages (Duncan et al., 1998). 
 The third class, tetrahydropyrimidines or pyrantel salts, are acetylcholine 
agonists and cause continuous firing of impulses at the neuro-muscular junction of 
nematodes, resulting in tonic paralysis (Austin et al., 1991).  Pyrantel pamoate (trans-1-
methyl-1,4,5,6-tetrahydro-2[2 (2 thienyl)vinyl] pyrimidine pamoate) was found to have a 
92 to 100% efficacy against adult ascarids and a 100% efficacy against immature 
ascarids when fed at a rate of 6.6 mg/kg BW via stomach tube or with feed (Lyons et al., 
1974).  Pyrantel pamoate also had an 89 to 96% efficacy against small strongyles (Lyons 
et al., 1974). In contrast to these early reports the effectiveness of anthelmintics, 
nematodes have developed resistance to one or more class of drug(s).   
Resistance 
 Clayton (1980) first defined resistance as a fecal egg count reduction of less than 
70% at 7 to 14 d post treatment.  However, this is probably somewhat of a conservative 
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measure.  The World Association for the Advancement of Veterinary Parasitology 
(WAAVP) published recommendations for standardizing procedures to detect nematode 
resistance (Coles et al., 1992).  They defined resistance in sheep and goats as a reduction 
in fecal egg counts of less than 95% with a lower confidence limit of less than 90%.  
There was only a brief mention of the problem in horses, indicating a reduction in fecal 
egg counts of less than 90% as indicative of benzimidazole resistance.  This is the only 
drug class they mentioned and gave no justification for this recommendation (Bauer et 
al., 1986).  Kaplan (2002) advised that there must be established standards for 
performing and analyzing fecal egg count reduction tests in order to evaluate the 
magnitude and prevalence of resistance internationally.  Furthermore, since there are 
variations in efficacies among drug classes against susceptible cyathostomes, a universal 
standard is probably not useful.  The previously recommended 90% reduction level is 
probably fair for benzimidazoles for declaring resistance.  However, ivermectin 
treatment consistently gives nearly a 100% reduction in FEC, therefore the appearance 
of any eggs following treatment is cause for concern.  Accordingly, a definition of 
resistance for ivermectin of < 95% may be too conservative, and a more stringent 
definition is required.  Pyrantel has variable and much lower efficacies, even when first 
introduced; consequently a much more conservative definition of resistance is required 
(Kaplan, 2002). 
 The first report of small strongyle drug resistance in horses was to phenothiazine, 
which is no longer available in the United States.  In the mid-1960’s, small strongyles 
were found to be resistant to thiabendazole (Lyons et al., 1999).  Drudge et al. (1979) 
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found five species of small strongyles to be resistant to thiabendazole, along with 
resistance to mebendazole, cambendazole, fenbendazole, and oxfenbendazole with fecal 
egg count reductions of only 40 to 98%.  Only oxibendazole was 100% effective with a 
complete elimination of small strongyles (Drudge et al., 1979).  Widespread 
benzimidazoles-resistant small strongyles are found in the United States (Lyons et al., 
1996; Lyons et al., 1999; Tarigo-Martinie et al., 2001; Kaplan, 2002; Kaplan et al., 
2004) and 20 other countries (Lyons et al., 1999).   
 Small strongyle resistance to pyrantel has also been reported in the United States 
(Chapman et al., 1996; Woods et al., 1998; Lyons et al., 2001; Tarigo-Martinie et al., 
2001), Norway (Ihler, 1995) and Denmark (Craven et al., 1998; Craven et al., 1999).  It 
is speculated that the common practice of low-dose (2.64 mg/kg BW) daily feeding of 
pyrantel tartrate is one of the primary factors for increasing resistance in the United 
States (Kaplan, 2002).  The study conducted by Tarigo-Martinie et al. (2001), found the 
mean reduction of egg counts to be only 89% at 14 d post treatment with pyrantel on 7 
farms.  One farm had no reduction in fecal egg count (FEC) 2 wk after treatment, 
indicating that resistance of cyathostomes to pyrantel was high on that farm.  This was 
the only farm with a history of daily pyrantel tartrate use, giving support to the theory of 
this facilitation of resistance (Tarigo-Martinie et al., 2001). 
 The first observation of an equine nematode showing resistance to ivermectin 
was found in the Netherlands in 2000.  Boersema et al. (2002) found that ivermectin was 
ineffective in controlling Parascaris infection in a small number of foals on a single 
farm.  Since then Parascaris resistance to ivermectin has been identified in Canada 
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(Hearn and Peregrine, 2003; Slocombe et al., 2007), Kentucky (Lyons et al., 2006), 
Texas (Craig et al., 2007), and recently Sweden (Lindgren et al., 2008).  Hearn and 
Peregrine (2003) observed a high number of ascarid eggs 12 to 13 d after treatment with 
ivermectin.  In Canada, it was found that the overall efficacy of ivermectin was only 
34% in foals, while fenbendazole and pyrantel pamoate had an efficacy of 98% 
(Slocombe et al., 2007).  On the Texas horse farm, the same one as used in the present 
study, it was found that ivermectin was inadequate in removing ascarids after treatment, 
and there was even a significant increase in egg counts indicating maturation of worms 
already present in the intestine.  The product, however, was more effective in foals 
greater than 8 mo of age (Craig et al., 2007). 
 This represents a unique problem in the young horse whereas they are plagued by 
two different nematodes that are resistant to different anthelmintics.  One nematode 
(small strongyles) is resistant to more than one type of drug (pyrantel and fenbendazole), 
whereas the other nematode (Parascaris) is resistant to a different class (ivermectin).  
Therefore, an adequate method of control for both must be found.  Considerations when 
administering treatments against resistant nematodes include: realization of the 
additional cost of increasing dosages of anthelmintics and possible toxic reactions to the 
drugs.  The toxicosis factor for fenbendazole is 100x the recommended dose; it is 20x 
the recommended dose for pyrantel; but only 6x the recommended dose for ivermectin.  





 In other host species, such as sheep and goats, combinations of anthelmintics 
have been used with positive results against resistant nematodes (Bennet et al., 1980; 
Anderson et al., 1988; Waller et al., 1990; Anderson et al., 1991; Miller and Craig, 
1996).  Combinations do not produce toxic effects in the host because of differing modes 
of action and the administration of each drug at its recommended dose.  Resistance by 
sheep and goat nematodes, such as Haemonchus contortus, to more than one class of 
anthelmintic is highly prevalent.  It is debated as to whether the combinations of drugs 
act by a synergistic or an additive effect.  Bennet et al. (1980) described a synergistic 
effect, as the two drugs used had different modes of action; therefore a possible 
interaction was obtained.  They found that treatment with mebendazole or levamisole 
alone caused no significant decrease in egg counts when administered to sheep with 
benzimidazole resistant Haemonchus contortus.  However, when administered together, 
a reduction of 80% was found (Bennet et al., 1980).  Anderson et al. (1991) described an 
additive effect, although comparison of the two studies is difficult because different 
worms and drugs were investigated.  There was a reduction in resistant Ostertagia 
species and Trichostrongylus colubriformis of 97 to 98% and 95 to 100%, respectively 
when sheep were administered combinations of albendazole and levamisole.  Reductions 
of only 80 to 90% (Ostertagia) and 36 to 86% (T. colubriformis) were found when the 
drugs were administered singly (Anderson et al., 1991).  Miller and Craig (1996) found 
that the combination of fenbendazole and levamisole resulted in efficacies of 62% when 
administered to goats with multiple resistant H. contortus.  This reduction is not enough 
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to be clinically effective, but is more successful than the efficacy of 1 to 23% observed 
when the drugs were used solely (Miller and Craig, 1996). 
 An adequate strategy must be implemented to control resistant parasites in foals.  
Difficulty arises since one nematode is resistant to one class of drug, while another 
nematode in the same animal is resistant to another drug class.  Drug combinations, as 
used in other hosts, may therefore be strategy to adequately control both parasites were 
resistance is found in foals. 
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CHAPTER III 
MATERIALS AND METHODS 
 
Management of horses 
 Twenty-eight Quarter Horse foals were utilized for the study.  The study began 
when each foal was 60 d of age and ended between 174 and 270 d of age, when the 
youngest foal reached 174 d of age.  All foals were from the breeding herd at Texas 
A&M University Horse Center and were managed consistently regarding vaccinations 
and health care.  All foals were maintained at the Texas A&M University Horse Center, 
all experimental procedures were approved by the Institutional Agricultural Animal Care 
and Use Committee (AUP# 2007-68). 
 All foals were maintained on pasture from the time of birth until weaning at an 
average of 120 d of age.  From d 120 until an average of d 200, they were housed as 
groups in dry lot pens, and fed individually twice daily.  They were fed 1.5% of BW in 
concentrate and 0.75% of BW in Coastal Bermudagrass hay.  At d 200, the foals were 
returned to pasture.  All foals had ad libitum access to water.  Each foal was weighed 
every 7 d before feeding or measured with a weight tape to allow for adjustment of their 
diets and accurate treatment dose. 
Treatments 
 Foals were assigned into groups (n=4) based on their birthdates and then 
randomly assigned to a treatment regimen within their group (Table 1).  Group I was 
first administered ivermectin (IVM) at 0.2mg/kg BW.  Group II was first administered 
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ivermectin at 0.2 mg/kg BW and pyrantel pamoate at 6.6 mg/kg BW (IVM+PRT).  
Group III was first administered ivermectin at 0.2 mg/kg BW and fenbendazole at 10 
mg/kg BW (IVM+FBZ).  Group IV was first administered pyrantel pamoate at 6.6 
mg/kg BW and fenbendazole at 10 mg/kg BW (PRT+FBZ).  Each dosage was based 
upon the manufacturer’s recommendation.  Ivermectin was administered orally in a 
liquid (Merial Limited, Duluth, GA) and PRT (Columbia Laboratories, Lexington, KY) 
and FBZ (InterVet Inc., Millsboro, DE) in paste formulations.  After 30 d, each group 
was administered a different drug/combination.  That is group I was treated as group II, 
group II as group III, group III as group IV, and group IV as group I.  Each group was 
rotated through the same treatment regimen and received each treatment at least once 
over a period of 4 mo.   
Fecal analysis 
 Fecal samples were taken before treatment and 14 d post-treatment to determine 
the number of eggs (small strongyle and Parascaris) per gram of feces by confining 
foals to a 12’x12’ stall and waiting until defecation occurred.  Eggs per gram (EPG) 
were determined via the modified McMaster method (Herd, 1992) with a sensitivity of 
50 eggs per g.  Twenty-eight ml saturated salt solution (specific gravity of 1.20) and 2 g 
of feces were placed in a vial.  The fecal material was well mixed and subsamples were 
removed from the mixture with a large bore pipette.  The mixture was then added to a 
counting slide with two grids and examined under 100 x magnification.  Eggs were 
counted and the total number of eggs in both grids was multiplied by 50 to achieve EPG  
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Table 1. Anthelmintic treatment regimen for foals (60 – 150 d) 
Treatment groups Drugs administered Age of foals (days) 
   
Group I IVM 0.2 mg/kg 60 
 IVM + PRT 90 
 IVM + FBZ 120 
 PRT + FBZ 150 
   
Group II IVM 0.2 mg/kg + PRT 6.6 mg/kg 60 
 IVM + FBZ 90 
 PRT + FBZ 120 
 IVM 150 
   
Group III IVM 0.2 mg/kg + FBZ 10 mg/kg 60 
 PRT + FBZ 90 
 IVM 120 
 IVM + PRT 150 
   
Group IV PRT 6.6 mg/kg + FBZ 10 mg/kg 60 
 IVM 90 
 IVM + PRT 120 
  IVM + FBZ 150 
 
 
 (Herd, 1992).  If Parascaris eggs were not detected by the McMaster method, then a 5-g 
Wisconsin double centrifugation (Todd et al., 1975) was performed, with a sensitivity of 
0.2 EPG of feces.  Five g of feces was mixed in tap water, and then strained using cheese 
cloth, and sedimented in water by centrifugation for 5 min at 275 g.  The separated fluid 
was then removed.  The remaining material, including eggs, was mixed into a sucrose 
solution (specific gravity of 1.27) and then spun up against a coverslip by centrifuging 
10 min at 275 g.  The coverslip was then placed on a slide and examined under 100x 
magnification and all eggs were counted to achieve eggs per gram (Todd et al., 1975). 
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Fecal egg count reduction (FECR) was calculated by the equation: [(Mean EPG prior to 
treatment – mean EPG 14 d post-treatment)/mean EPG prior to treatment] x 100. 
Statistical analyses 
 Following the completion of fecal collections and determination of EPG in the 
fecal samples, the mean effects for each treatment were measured using the MIXED 
procedure of SAS (SAS Inst. Inc., Cary, NC) for repeated measures (Littell et al., 1996).  
The model contained effects for treatment and allowed for random effects of each 
individual.  Main effects considered significant when P < 0.05 and considered a trend 





Small strongyles  
 Results of small strongyle FEC, for every treatment (n = 139 fecal samples) are 
presented in Table 2.  Ivermectin was the only treatment that caused a significant (P < 
0.001) decrease in FEC 14 d post treatment.  Percent FEC reduction was also the highest 
at 99.72 ± 9.77%.  There was a significant difference between treatments when 
comparing IVM vs. IVM+PRT (P = 0.0018), IVM vs. IVM+FBZ (P = 0.0010), and IVM 
vs. PRT+FBZ (P < 0.0001).  There was a tendency for treatment with PRT+FBZ to be 
different from IVM+FBZ and IVM+PRT (P < 0.11) and no difference when comparing 
treatment with IVM+PRT vs. IVM+FBZ (P = 0.83).  There was an increase of over 
200% in FEC after treatment with PRT+FBZ, while all other treatments resulted in 
clinically significant reductions in FEC (Table 2).   
 
 
Table 2. Fecal egg counts (eggs per g feces) for small strongyles found in foals-all treatments 
  
 
      
Treatment Before Treatment 14-d post treatment Differencea % Reductionb 
IVM 29.47 ± 53.61 0.08 ±   0.27 29.39 ± 53.65c 99.72 ±     9.77 
IVM+PRT   5.78 ± 18.44 0.34 ±   1.51 5.44 ± 18.18d 94.14 ±   69.70 
IVM+FBZ 4.41 ± 16.93 0.57 ±   1.91 3.85 ± 17.16d 87.18 ± 133.97 
PRT+FBZ 3.58 ±   9.32 11.91 ± 21.55 -8.32 ± 20.95d -232.40 ± 626.65 
a
 Difference obtained from Before treatment – 14 d post treatment 
b
 % Reduction obtained from [(before treatment – 14 d post treatment)/before treatment] x 100 
c,d




 Analysis was conducted using the first treatment data for each foal (n = 28 fecal 
samples).  This was conducted since all treatments were given in the same order, and 
thus necessary to be able to distinguish effects from previous treatments.  Results are 
presented in Table 3.  The treatment of PRT+FBZ was significantly less effective than 
IVM+PRT (P < 0.05) and tended to be less effective than IVM (P = 0.14) and 
IVM+FBZ (P = 0.12).  Again, treatment with PRT+FBZ resulted in an increase in FEC 
14 d post treatment.  The most successful treatment was IVM+PRT with a % reduction 
of 99.05%.   Treatments with IVM and IVM+FBZ resulted in a positive reduction, but 








Table 3. Fecal egg counts (eggs per g feces) for small strongyles found in foals-first treatment 
  
 
      
Treatment Before Treatment 14-d Post Treatment Difference % Reduction 
IVM 1.17 ±   1.39 0.31 ±   0.54 0.86 ±     1.49c 73.17 ±   20.37 
IVM+PRT 9.00 ± 17.30 0.09 ±   0.15 8.91 ± 106.77a 99.05 ±   78.68 
IVM+FBZ 2.94 ±   4.44 1.00 ±   2.39 1.94 ±     4.44c 66.02 ± 237.48 
PRT+FBZ 3.88 ±   8.31 15.66 ± 40.26 -11.78 ±     8.31b -303.78 ± 275.79 
a,b,c




 Results of Parascaris FEC for all treatments (n = 139 fecal samples) are 
presented in Table 4.  There was no influence of treatment on Parascaris EPG (P > 
0.12).  However, when considering the % reduction, there was an increase in FEC post 
treatment when treated with IVM.  Treatment with IVM+FBZ was the only treatment 
that resulted in a positive reduction that indicates the combination was effective.  
Treatments of IVM+PRT and PRT+FBZ resulted in positive FEC reductions, however, 
were below expected efficacies (Table 4). 
 




   
Treatment Before Treatment 14-d post treatment Difference % Reduction 
IVM 0.08 ±   0.30 2.10 ±   7.66 -2.02 ± 54.54a -2646.15 ± 528.17 
IVM+PRT 26.43 ± 75.70 12.71 ± 58.32 13.72 ± 98.03a 51.91 ±   81.96 
IVM+FBZ 8.58 ± 28.92 0.11 ±   0.47 8.46 ± 28.85a 98.67 ±     1.45 
PRT+FBZ 0.39 ±   1.22 0.27 ±   0.98 0.13 ±   1.11a 32.31 ±   19.89 
a





 In regards to small strongyles, the results of this study agree with those of 
previous studies.  Both pyrantel and fenbendazole administration resulted in less than a 
90% reduction in small strongyle egg counts 2 wk after treatment, which indicates 
resistance to these drugs (Drudge et al., 1979; Chapman et al., 1996; Lyons et al., 1996, 
Woods et al., 1998; Lyons et al., 1999; Lyons et al., 2001; Tarigo-Martinie et al., 2001; 
Kaplan, 2002; Kaplan et al., 2004).  It is logical that a combination of these drugs 
(PRT+FBZ) would be less effective (difference of -8.32 EPG; P < 0.05) in controlling 
small strongyles in foals compared to the other treatments (IVM, IVM+PRT, 
IVM+FBZ) used in this study.  Treatment with IVM resulted in the highest % reduction 
(99.72%), while PRT+FBZ caused an increase in FEC 14 after treatment.   
 Negative EPG differences or negative % reductions indicate a failure of the drug 
to control worm populations as a result of maturation and resistance.  Ivermectin, when 
used alone or in combination, continues to be effective in controlling the small strongyle 
population in this study.  However, the use of ivermectin combinations did not have any 
greater success than ivermectin used alone (P < 0.002).  This could have been due to 
competitive inhibition of fenbendazole or pyrantel, which small strongyles are resistant 
to, with ivermectin, which they are not.  More research must be conducted to confirm 
this finding. 
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 Analyses based solely on the first treatment were conducted due to the fact that 
the prepatent period of small strongyles is 40 to 100 d (Reinemeyer, 1986; Lyons et al., 
2000).  All treatments were administered 30 d apart, so a subsequent treatment could 
have been administered before mature, egg producing adult worms were established in 
the large intestine.  Since all treatments were administered in the same order with no 
wash out period in between, one treatment may have had an influence on the findings of 
a subsequent treatment.  When a treatment is administered before an adult population is 
established, it would cause lower pre-treatment FEC, creating the appearance that a 
treatment was ineffective in controlling the population due to subsequent worm 
maturation when a greater post-treatment EPG was found.  In addition, when a drug is 
administered, it only kills the nematodes residing within the lumen of the intestine.  In 
the case of small strongyles, the encysted larval stages are protected from the action of 
the anthelmintics.  In fact, it has been suggested that therapeutic removal of adult 
cyathostomes from the lumen may cause emergence of larvae from the intestinal wall 
(Reinemeyer, 1986).  This is evident by the resumption of egg production from 
previously encysted strongyles soon after treatment. 
 The differences in EPG before and after treatment for Parascaris were not 
significantly different depending on treatment, but there was a tendency for ivermectin 
to be less effective in controlling the worm population.  This is supported by a study 
conducted at the same facility (Craig et al., 2007) where ivermectin failed to reduce the 
Parascaris population in the horse.  An increase in post-treatment EPG was observed, 
indicating maturation of ascarids already in the intestinal tract.  A negative % reduction 
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(-2646%) was observed, indicating failure of ivermectin against Parascaris.  Studies 
conducted elsewhere (Boersema et al., 2002; Hearn and Peregrine, 2003; Slocombe et 
al., 2007; Lyons et al., 2006; Lindgren et al., 2008) indicate the idea that ivermectin is 
not always effective in controlling Parascaris infections in young horses.  The 
combinations of IVM+FBZ caused the highest % reduction (98.67%), while IVM+PRT 
and PRT+FBZ caused much lower, 51.91 and 32.31% respectively, and therefore are not 
considered clinically effective. 
 Again, perceived negative differences could have been due to worm maturation 
or indicative of resistance.  However, since foals were treated consecutively with 
different treatments, if there had been an overwhelming success of a prior treatment 
before the ascarids reached maturity, it could have masked the perceived effects of a 
subsequent treatment.  First treatment data for Parascaris was excluded from analysis 
due to the lack of positive before treatment fecal egg counts.  This was probably due to 
the immaturity of the nematodes in foals at 60 d. 
 Failure to see significant results in this study could be due to the fact that the 
foals were first treated before worms reached maturity.  Foals become infected soon 
after birth but the prepatent period, the time from infection until eggs are seen 
(indicating mature adult parasites), is 72 to 110 d (Clayton, 1986).  Since females are 
extremely fecund and capable of laying greater than 50 million eggs per d per foal, care 
was taken to administer an anthelmintic before this time.  Given that Parascaris eggs are 
extremely environmentally resistant (Clayton, 1986), it is advantageous to try and limit 
the number of eggs contaminating the pasture where the foals are housed to limit 
 23 
infection of future generations of foals.  Also, since Parascaris do not have the arrested 
development of larvae in the intestinal wall like cyathostomes, immature worms, 
maturing in the intestine for 2 mo prior to egg-laying capabilities, larvae should have 
been removed via anthelmintics before they reached maturity. 
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CHAPTER VI 
SUMMARY AND CONCLUSIONS 
 
 Since anthelmintic resistance is increasing among nematode populations that 
plague horses, an adequate control strategy must be put into place.  Conclusions from 
this study were that no anthelmintic was more effective than others in controlling small 
strongyles and ascarids.  However, it was found that the mixture of pyrantel and 
fenbendazole was ineffective in controlling small strongyle populations.  Further 
research is needed to find an adequate strategy to control multiple nematodes in young 
horses that are resistant to different classes of anthelmintics. 
 If one were to conduct a similar study, it would be advantageous to make some 
changes.  First, it would be better to wait until there was a positive diagnosis of adult 
worms of both species before administering the first treatment.  Also be beneficial to 
increase the time period between treatments to allow reestablishment of parasites in the 
intestines to better test the efficacy of a subsequent anthelmintic.  Finally, treatments 
should be randomized to as to get more accurate representation of the efficacy of a single 
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1 1 0 0 I 0 0.6 
2 1 0.2 0 I 0 0 
3 1 3.8 0 I 1.2 0 
4 1 0.6 0 I 0 0 
5 1 2.2 0 I 1 0 
6 1 0.2 0 I 0 0 
7 1 1.2 0 I 0 0.2 
23 2 5.4 0 I 0 42.8 
24 2 2.8 0 I 0 0 
25 2 1.6 0 I 0 0 
26 2 47 0 I 0 0 
27 2 55.4 0.2 I 0.2 0 
28 2 1.2 0 I 0 0 
17 3 0 0 I 0 0 
18 3 11 0 I 0 0 
19 3 100 0 I 0 0 
20 3 21.4 0 I 0.2 0 
21 3 17 0 I 0 9.2 
22 3 100 0 I 0 0 
11 4 5 0 I 0.2 0 
12 4 22.2 0 I 0 0 
13 4 150 0 I 0 0 
14 4 250 0 I 0 0 
15 4 3.6 0.8 I 0 8.4 
1 5 35 0 I 0 0 
2 5 2.4 0 I 0 0 
3 5 0.4 0 I 0 0 
4 5 2.4 0 I 0 0 
5 5 100 1.6 I 0 10 
6 5 10 0 I 0 0.2 
7 5 32 0 I 0 0 
23 6 16.6 0 I 0 0 
24 6 1.4 0 I 0 0 
25 6 0 0 I 0 0 












9 1 0.2 0 I P 0 0 
10 1 0.2 0 I P  0.2 0 
11 1 0.2 0 I P 0.4 0 
12 1 9 0 I P 0 0 
13 1 50 0 I P 0 350 
14 1 0.2 0 I P 0 0 
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